tiprankstipranks
Trending News
More News >
Morepen Laboratories Limited (IN:MOREPENLAB)
:MOREPENLAB
India Market
Advertisement

Morepen Laboratories Limited (MOREPENLAB) Stock Forecast & Price Target

Compare
4 Followers
See the Price Targets and Ratings of:

MOREPENLAB Financial Forecast

MOREPENLAB Earnings Forecast

The previous quarter’s earnings for MOREPENLAB were ₹0.20.
The previous quarter’s earnings for MOREPENLAB were ₹0.20.

MOREPENLAB Sales Forecast

The previous quarter’s earnings for MOREPENLAB were ₹4.25B.
The previous quarter’s earnings for MOREPENLAB were ₹4.25B.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on IN:MOREPENLAB
TR | OpenAI - 4o
TR | OpenAI - 4o
₹68₹67
Hold
42.77%
Upside
Reiterated
07/19/25
AI Generated ArticleAI Generated Article
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on IN:MOREPENLAB
TR | OpenAI - 4o
TR | OpenAI - 4o
₹68₹67
Hold
42.77%
Upside
Reiterated
07/19/25
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

MOREPENLAB Analyst Recommendation Trends

Rating
Jul 25
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
total
1
In the current month, MOREPENLAB has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. MOREPENLAB average Analyst price target in the past 3 months is 67.00.
Each month's total comprises the sum of three months' worth of ratings.

MOREPENLAB Stock Forecast FAQ

What is IN:MOREPENLAB’s average 12-month price target, according to analysts?
Based on analyst ratings, Morepen Laboratories Limited’s 12-month average price target is 67.00.
    What is IN:MOREPENLAB’s upside potential, based on the analysts’ average price target?
    Morepen Laboratories Limited has 42.77% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Morepen Laboratories Limited a Buy, Sell or Hold?
          Morepen Laboratories Limited has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Morepen Laboratories Limited’s share price target?
            The average share price target for Morepen Laboratories Limited is 67.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is ₹67.00 ,and the lowest forecast is ₹67.00. The average share price target represents 42.77% Increase from the current price of ₹46.93.
              What do analysts say about Morepen Laboratories Limited?
              Morepen Laboratories Limited’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of Morepen Laboratories Limited?
                To buy shares of IN:MOREPENLAB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis